The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research

McKnight, Patrick E., Kashdan, Todd B.·2009·Clinical Psychology Review
DOI 10.1016/j.cpr.2009.01.005

Cited by (400)

Items 101–200 of 400

  1. Predictors of functional improvement in employed adults with major depressive disorder treated with desvenlafaxine
    Raymond Wing Moon Lam, Jean Endicott, Ming‐Ann Hsu, Rana S. Fayyad, Christine J. Guico‐Pabia, Matthieu Boucher · 2014 · International Clinical Psychopharmacology
  2. Optimal Well-Being After Major Depression
    Jonathan A. Rottenberg, Andrew R. Devendorf, Vanessa Panaite, David J. Disabato, Todd B. Kashdan · 2019 · Clinical Psychological Science
  3. Beyond symptom improvement: transdiagnostic and disorder‐specific ways to assess functional and quality of life outcomes across mental disorders in adults
    Christoph Ulrich Correll, Samuele Cortese, Marco Solmi, Tommaso Boldrini, Koen Demyttenaere, Katharina Domschke, Paolo Fusar‐Poli, Philip A. P. M. Gorwood, Philip D. Harvey, Richard S.E. Keefe et al. · 2025 · World Psychiatry
  4. Symptom centrality and infrequency of endorsement identify adolescent depression symptoms more strongly associated with life satisfaction
    Michael C Mullarkey, Igor Marchetti, Karen Bluth, Caryn L. Carlson, Jason Shumake, Christopher G. Beevers · 2021 · Journal of Affective Disorders
  5. A longitudinal examination of psychosocial impairment across the anxiety disorders
    Kristin Naragon‐Gainey, Matthew W. Gallagher, Timothy A. Brown · 2013 · Psychological Medicine
  6. Cognitive-reminiscence therapy and usual care for depression in young adults: study protocol for a randomized controlled trial
    David John Hallford, David John Mellor · 2013 · Trials
  7. Body Mass Index (BMI) and risk of depression in adults: A systematic review and meta-analysis of longitudinal studies
    Sohrab Amiri, Sepideh Behnezhad, Karim Babaei Nadinlui · 2018 · Obesity Medicine
  8. Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study
    Josep Maria Haro, Lene Hammer-Helmich, Delphine Saragoussi, Anders Ettrup, Klaus Groes Larsen · 2019 · Neuropsychiatric Disease and Treatment
  9. The Importance of Symptom Reduction for Functional Improvement after Cognitive Behavioral Therapy for Anxiety and Depression: A Causal Mediation Analysis
    Otto R.F. Smith, Leif Edvard Aarø, Marit Knapstad · 2023 · Psychotherapy and Psychosomatics
  10. The phenomenological characteristics of autobiographical future thinking in dysphoric and non-dysphoric individuals
    David John Hallford · 2018 · Psychiatry Research
  11. Factors predicting the long-term illness course in a cohort of depressed inpatients
    Christine Kuehner, Silke Huffziger · 2012 · European Archives of Psychiatry and Clinical Neuroscience
  12. Using Neuroscience to Augment Behavioral Interventions for Depression
    Meghan Vinograd, Michelle G. Craske · 2020 · Harvard Review of Psychiatry
  13. Gender differences in quality of life and functional disability for depression outpatients with or without residual symptoms after acute phase treatment in China
    Na Zhao, Xiaohong Wang, Wenyuan Wu, Yongdong Hu, Yajuan Niu, Xueyi Wang, Chengge Gao, Ning Zhang, Yiru Fang, Huang Jizhong et al. · 2017 · Journal of Affective Disorders
  14. Risk and risk factors for disability pension among patients with treatment resistant depression– a matched cohort study
    Heidi T. Taipale, Johan Reutfors, Antti J. Tanskanen, Lena Brandt, Jari Tiihonen, Allitia DiBernardo, Ellenor Mittendorfer‐Rutz, Philip Brenner · 2020 · BMC Psychiatry
  15. Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes
    Spielmans, Glen I., Berman, Margit I., Linardatos, Eftihia, Rosenlicht, Nicholas Z., Perry, Angela, Tsai, Alexander C. · 2016 · Focus
  16. Trajectories and determinants of functional limitations in late-life depression: A 2-year prospective cohort study
    Wassink-Vossen, Sanne, Collard, Rose M., Wardenaar, Klaas J., Verhaak, Peter F.M., Rhebergen, Didi, Naarding, Paul, Voshaar, Richard C. Oude · 2019 · European Psychiatry
  17. The varying burden of depressive symptoms across adulthood: Results from six NHANES cohorts
    Regina García Velázquez, Markus M. Jokela, Tom Henrik Rosenström · 2018 · Journal of Affective Disorders
  18. Emerging Adulthood and Prospective Depression: A Simultaneous Test of Cumulative Risk Theories
    Joseph R. Cohen, Kari N. Thomsen, Anna Racioppi, Sergi Ballespí, Tamara Sheinbaum, Thomas Richard Kwapil, Neus Barrantes-vidal A · 2019 · Journal of Youth and Adolescence
  19. Daily Life Positive Events Predict Well-Being Among Depressed Adults 10 Years Later
    Vanessa Panaite, Andrew R. Devendorf, Todd B. Kashdan, Jonathan A. Rottenberg · 2021 · Clinical Psychological Science
  20. Facilitating communication for critically ill patients and their family members: Study protocol for two randomized trials implemented in the U.S. and France
    Jared Randall Curtis, Nancy Kentish‐Barnes, Lyndia C. Brumback, Elizabeth L. Nielsen, Kathryn I. Pollak, Patsy D. Treece, Lisa Hudson, Gigi Garzio, Jennifer Im, Bryan Jeffrey Weiner et al. · 2021 · Contemporary Clinical Trials
  21. Behavioral Activation, Depression, and Promotion of Health Behaviors: A Scoping Review
    David May, Boris Litvin, John Philip Allegrante · 2022 · Health Education & Behavior
  22. Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study
    Wang, Gang, Xiao, Le, Ren, Hongye, Simonsen, Kenneth, Ma, Jingdong, Xu, Xiangdong, Guo, Ping, Wang, Zhiren, Bai, Ludong, Heldbo Reines, Elin et al. · 2022 · Neuropsychiatric Disease and Treatment
  23. Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder
    Angelo Sambunaris, Carl Gommoll, Changzheng Chen, William M. Greenberg · 2014 · International Clinical Psychopharmacology
  24. Improving work outcomes of dysthymia (persistent depressive disorder) in an employed population
    David A. Adler, Debra Lerner, Zachary L. Visco, Annabel Greenhill, Hong Chang, Elina Cymerman, Francisca Azocar, William H. Rogers · 2015 · General Hospital Psychiatry
  25. Symptomatic and functional recovery in depression in later life
    Rose M. Collard, Sanne Wassink‐Vossen, Aart H. Schene, Paul Naarding, Peter F.M. Verhaak, Richard C. Oude Voshaar, Hannie C. Comijs · 2018 · Social Psychiatry and Psychiatric Epidemiology
  26. Comorbid social anxiety disorder in clients with depressive disorders: predicting changes in depressive symptoms, therapeutic relationships, and focus of attention in group treatment.
    T. Kashdan, John E. Roberts · 2011 · Behaviour Research and Therapy
  27. Childhood ADHD
    Laura Batstra, Edo H. Nieweg, Sip-Jan Pijl, Donald G. van Tol, Mijna Hadders‐Algra · 2014 · Journal of Psychiatric Practice
  28. On climate anxiety and the threat it may pose to daily life functioning and adaptation: A study among European and African French-speaking participants
    Alexandre Heeren, Camille Mouguiama-Daouda, Alba Contreras · 2021
  29. Fatigue and occupational functioning in major depressive disorder
    Raymond Wing Moon Lam, Gin Singh Malhi, Roger S. McIntyre, Koen Demyttenaere, Philip A. P. M. Gorwood, Erin E. Michalak, Ulrich Hegerl · 2013 · Australian & New Zealand Journal of Psychiatry
  30. The 12-item WHO Disability Assessment Schedule II as an outcome measure for treatment of common mental disorders
    Catherine Thomas, Sujit D. Rathod, M.J. De Silva, Helen Anne Weiss, Vikram Patel · 2016 · Cambridge Prisms Global Mental Health
  31. A Systematic Review of the Measurement of Function in Late-Life Depression
    Kathleen S. Bingham, Sanjeev Kumar, DEIRDRE R. DAWSON, Benoit H. Mulsant, Alastair J. Flint · 2017 · American Journal of Geriatric Psychiatry
  32. The Psychometric Properties of the Polish Version of the Acceptance and Action Questionnaire-II (AAQ-II)
    Bartosz Kleszcz, Joanna E. Dudek, Wojciech Białaszek, Paweł Ostaszewski, Frank W. Bond · 2018 · Studia Psychologiczne (Psychological Studies)
  33. Adjunctive Brexpiprazole and Functioning in Major Depressive Disorder: A Pooled Analysis of Six Randomized Studies Using the Sheehan Disability Scale
    Mary Hobart, Peter G. Y. Zhang, Catherine Weiss, Stine Rasmussen Meehan, Hans Eriksson · 2018 · The International Journal of Neuropsychopharmacology
  34. The relationship between personality, social functioning, and depression: A structural equation modeling analysis
    Wai Shing Tse, Tina Louisa Rochelle, Jacky C. K. Cheung · 2011 · International Journal of Psychology
  35. Canadian Network for Mood and Anxiety Treatments (Canmat) Consensus Recommendations for Functional Outcomes in Major Depressive Disorder
    Lam, Raymond W., Parikh, Sagar V., Michalak, Erin E., Dewa, Carolyn S., Kennedy, Sidney H. · 2015 · Annals of Clinical Psychiatry
  36. The impact of their role on telephone crisis support workers' psychological wellbeing and functioning: Quantitative findings from a mixed methods investigation
    T. Kitchingman, P. Caputi, A. Woodward, C. Wilson, Ian G. Wilson · 2018 · PLoS ONE
  37. The Influence of Adverse Childhood Experiences (ACEs) on the Functional Impairment of Justice-Involved Adolescents: A Comparison of Baseline to Follow-Up Reports of Adversity
    Jacquelynn F. Duron, Abigail Williams‐Butler, Feng-Yi Y. Liu, Danielle Nesi, Kathleen Pirozzolo Fay, Bo‐Kyung Elizabeth Kim · 2021 · Youth Violence and Juvenile Justice
  38. Depression, violence and socioeconomic outcomes among refugees in East Africa: evidence from a multicountry representative survey
    Julia R Pozuelo, Raphael Bradenbrink, Maria Flinder Stierna, Olivier C. Sterck · 2023 · BMJ Mental Health
  39. Global absenteeism and presenteeism in mental health patients referred through primary care
    S. Kathleen Bailey, John Michael Haggarty, Sara Kelly · 2016 · Work
  40. Major Depressive Disorder (MDD) and Schizophrenia– Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A Review
    Jasmina Mallet, Philip A. P. M. Gorwood, Yann Le Strat, Caroline Dubertret · 2019 · The International Journal of Neuropsychopharmacology
  41. The "Heart" of depression during early adolescence.
    K. Tu, Xiaomei Li, Joseph R. Cohen · 2019 · Developmental Psychobiology
  42. The potential mediating role of anxiety sensitivity in the impact of mindfulness training on anxiety and depression severity and impairment: A randomized controlled trial
    Qiang Xie, Guan Ye, Stefan G. Hofmann, Ting Jiang, Xinghua Liu · 2022 · Scandinavian Journal of Psychology
  43. Objectively measured sedentary time and mental and cognitive health: Cross-sectional and longitudinal associations in The Rotterdam Study
    Chantal M. Koolhaas, Frank J.A. van Rooij, Desana Kocevska, Annemarie Ida Luik, M. Arfan Ikram, Oscar H. Franco, Henning W. Tiemeier · 2019 · Mental health and physical activity
  44. Optimal well-being in the aftermath of anxiety disorders: A 10-year longitudinal investigation
    David J. Disabato, Todd B. Kashdan, James D. Doorley, Kerry C. Kelso, Kristina M. Volgenau, Andrew R. Devendorf, Jonathan A. Rottenberg · 2021 · Journal of Affective Disorders
  45. Prevalence of mental disorders among middle-aged population of primary healthcare centers in Northeastern Iran
    Mehdi Talebi, Ali Taghipour, Amene Raouf-Rahmati, Ehsan Musa Farokhani, Saeed Ghaffariyan-Jam, Azadeh Samarghandi, Maryam Nemati, Ahmad Nemati · 2024 · BMC Public Health
  46. Functional competence in major depressive disorder: Objective performance and subjective perceptions
    Melissa Milanovic, Katherine Holshausen, Roumen V. Milev, Christopher R. Bowie · 2018 · Journal of Affective Disorders
  47. Evaluation of the CORE-10 to assess psychological distress in pregnancy
    Rose Coates, Susan Ayers, Richard Oliver de Visser, Alexandra Thornton · 2019 · Journal of Reproductive and Infant Psychology
  48. Changes in depression subtypes for women during treatment with citalopram: a latent transition analysis
    Christine M. Ulbricht, Levent Dumenci, Anthony J. Rothschild, Kate L. Lapane · 2016 · Archives of Women s Mental Health
  49. Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
    Emmanuelle Weiller, Catherine Weiss, Christopher P. Watling, Christopher Edge, Mary Hobart, Hans Eriksson, Maurizio Fava M. D · 2017 · Neuropsychiatric Disease and Treatment
  50. Contributors of Functional Impairment in Major Depressive Disorder: a Biopsychosocial Approach
    Troy K. Chow, Christopher R. Bowie, Michael Morton, Aleksandra Lalovic, Shane J. McInerney, Sakina J. Rizvi · 2022 · Current Behavioral Neuroscience Reports
  51. Values and preferences related to workplace mental health programs and interventions: An international survey
    Jill Murphy, Jasmine M. Noble, Promit Ananyo Chakraborty, Georgia J. Michlig, Erin E. Michalak, Andrew James Greenshaw, Raymond Wing Moon Lam · 2023 · PLoS ONE
  52. Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder
    Michael E. Thase, Carl Gommoll, Changzheng Chen, Kenneth L. Kramer, Angelo Sambunaris · 2016 · International Clinical Psychopharmacology
  53. The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Vanessa C. Evans, Golnoush Alamian, Jane McLeod, Cindy Woo, Lakshmi N. Yatham, Raymond Wing Moon Lam · 2016 · CNS Drugs
  54. Cognitive dysfunction in Malaysian patients with major depressive disorder: A subgroup analysis of a multicountry, cross‐sectional study
    Nor Zuraida Zainal, Pranab Kalita, Keira Joann Herr · 2018 · Asia-Pacific Psychiatry
  55. The Relationship Between Depression Symptoms and Anxiety Symptoms During Acute ECT for Patients With Major Depressive Disorder
    Chun‐Jen Huang, Ching‐Hua Lin, Jyh-I Wu, Wei‐Cheng Yang · 2019 · The International Journal of Neuropsychopharmacology
  56. Comparative efficacy of pharmacological treatments on measures of self-rated functional outcomes using the Sheehan Disability Scale in patients with major depressive disorder: a systematic review and network meta-analysis
    Bing Cao, Lu Xu, Yan Chen, Dongfang Wang, Ye-Na Lee, J. Rosenblat, Xiao Gao, S. Zhan, F. Sun, R. McIntyre · 2021 · CNS Spectrums
  57. Minimal clinically important change in the MADRS anhedonia factor score: A pooled analysis of open-label studies with vortioxetine in patients with major depressive disorder
    Roger S. McIntyre, Oscar Necking, Simon Nitschky Schmidt, Elin Heldbo Reines · 2024 · Journal of Affective Disorders
  58. Psychological interventions for preventing relapse in individuals with partial remission of depression: a systematic review and individual participant data meta-analysis
    Joost Gülpen, Josefien Breedvelt, Eva A.M. van Dis, Gert J. Geurtsen, Fiona C Warren, Cornelis Van Heeringen, Caitlin Hitchcock, Fredrik Holländare, Marloes J. Huijbers, Robin B. Jarrett et al. · 2025 · Psychological Medicine
  59. Well-Being After Psychopathology: A Transformational Research Agenda
    Jonathan A. Rottenberg, Todd B. Kashdan · 2022 · Current Directions in Psychological Science
  60. The relationship between symptom relief and functional improvement during acute fluoxetine treatment for patients with major depressive disorder
    Ching‐Hua Lin, Li‐Shiu Chou, Ming‐Chao Chen, Cheng‐Chung Chen · 2015 · Journal of Affective Disorders
  61. Evaluation of functional health and well-being in patients receiving levomilnacipran ER for the treatment of major depressive disorder
    Steven I. Blum, Stavros Tourkodimitris, Adam Ruth · 2014 · Journal of Affective Disorders
  62. Practice nurse-led proactive care for chronic depression in primary care: A randomised controlled trial
    Marta Buszewicz, Mark Griffin, Elaine M. McMahon, Kate R Walters, Michael King · 2016 · The British Journal of Psychiatry
  63. Startle during threat longitudinally predicts functional impairment independent of DSM diagnoses
    Elizabeth S. Stevens, Lynne Lieberman, Carter J. Funkhouser, Kelly A. Correa, Stewart A. Shankman · 2019 · Psychiatry Research
  64. A qualitative exploration of patient perspectives on psychosocial burdens and positive factors in adults with osteogenesis imperfecta
    W. Conor Rork, Alyssa G. Hertz, Andrew D. Wiese, Kristin M. Kostick, Dianne D. Nguyen, Sophie C. Schneider, Whitney S. Shepherd, Hannah Cho, Members of the BBDC, Chaya Nautiyal Murali et al. · 2023 · American Journal of Medical Genetics Part A
  65. Heterogeneity in Depression Symptoms and Health Status Among Older Adults
    Pablo A. Mora, Teerah Beamon, LeAnn Preuitt, Marco DiBonaventura, Elaine A. Leventhal, Howard Leventhal · 2012 · Journal of Aging and Health
  66. Functional Impairment and Changes in Depression Subtypes for Women in STAR*D: A Latent Transition Analysis
    Christine M. Ulbricht, Anthony J. Rothschild, Kate L. Lapane · 2015 · Journal of Women s Health
  67. Are more responsive depression scales really superior depression scales?
    Eiko I. Fried · 2016 · Journal of Clinical Epidemiology
  68. Insights into cognitive work hardening for return-to-work following depression: Qualitative findings from an intervention study
    Adeena Wisenthal, Terry M. Krupa, Bonnie H. Kirsh, Rosemary M. Lysaght · 2019 · Work
  69. Identifying factors associated with the hospital readmission rate among patients with major depressive disorder
    Sharareh Parami, Leili Tapak, Jalal Poorolajal, Abbas Moghimbeigi, Ali Ghaleiha · 2021 · BMC Psychiatry
  70. Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
    Shengyuan Yu, Xiaofei Zhang, Lei Wu, Dongjun Wan, Ruozhuo Liu, Zhao Dong, Min Chen · 2015 · Neuropsychiatric Disease and Treatment
  71. Efficacy and safety of multiple doses of levomilnacipran extended-release for the treatment of major depressive disorder
    Qunlian Huang, Xiaoyan Zhong, Yun Ye, Bin Yu, Yilan Huang · 2016 · Neuropsychiatric Disease and Treatment
  72. Can the Risk of Severe Depression-Related Outcomes Be Reduced by Tailoring the Antidepressant Therapy to Patient Characteristics?
    Janie Coulombe, Erica E. M. Moodie, Susan M. Shortreed, Christel Renoux · 2020 · American Journal of Epidemiology
  73. Childhood Trauma Predicts Positive Expressive Suppression During Social Affiliation in Adults With Anxiety and/or Depression: Implications for Social Functioning
    Samantha N. Hoffman, Murray B. Stein, Charles T. Taylor · 2022 · Behavior Therapy
  74. Exploring the Effects of Major Depressive Disorder on Daily Occupations and the Impact of Psychotherapy: A Literature Review
    Kalliopi Iliou, Dimitrios Balaris, Anna Maria Dokali, Vasileios Fotopoulos, Athanasios Kouletsos, Aikaterini Katsiana · 2024 · Cureus
  75. Meshing Anxiety, Depression, Quality of Life, and Functionality in Chronic Disease
    Ana Pedro Costa, Irma da Silva Brito, Teresa Dionísio Mestre, Ana Matos Pires, Manuel José Lopes · 2025 · Healthcare
  76. Which residual symptoms predict relapse after successful electroconvulsive therapy for late-life depression?
    Simon Lambrichts, Kristof Vansteelandt, Kaat Hebbrecht, Margot J. Wagenmakers, Mardien Leoniek Oudega, Jasmien Obbels, Eric R. van Exel, Annemiek Dols, Filip Bouckaert, Didier L. Schrijvers et al. · 2022 · Journal of Psychiatric Research
  77. Italian psychiatrists’ perception on cognitive symptoms in major depressive disorder
    Umberto Albert, Roberto Brugnoli, Filippo Caraci, Bernardo Maria Dell’Osso, Guido Di Sciascio, Alfonso Antonio Vincenzo Tortorella, Claudio Vampini, Nazarena Cataldo, Valeria Pegoraro · 2015 · International Journal of Psychiatry in Clinical Practice
  78. Understanding the Impairment Associated With Depressive Symptoms
    Bjorn Hanson, Michael A. Young · 2016 · The Journal of Nervous and Mental Disease
  79. The Need for Functional Assessments in School-Based Mental Health Intervention Research
    Andrews, Jack L., Schweizer, Susanne · 2023 · JAMA Psychiatry
  80. Psychometric evaluation of a controlled social affiliation paradigm: Findings from anxiety, depressive disorder, and healthy samples
    Hoffman, Samantha N., Thomas, Michael L., Pearlstein, Sarah L., Kakaria, Sanskruti, Oveis, Christopher, Stein, Murray B., Taylor, Charles T. · 2021 · Behavior Therapy
  81. Long-term outcomes at 24- and 36-month follow-up in the intervention arm of the randomized controlled trial of Prompt Mental Health Care
    Otto R.F. Smith, Solbjørg Makalani Myrtveit Sæther, Ellen Haug, Marit Knapstad · 2022 · BMC Psychiatry
  82. Associations between Predictors of PTSD and Psychosocial Functioning in Veterans: Results from a Longitudinal Assessment Study
    Rahel Pearson, Carmen T. Mendoza, John David Coppin, Suzannah K. Creech · 2024 · Depression and Anxiety
  83. Antenatal depression in Sri Lanka: a qualitative study of public health midwives’ views and practices
    Sage Wyatt, Truls Østbye, Vijitha De Silva, Qian Long · 2022 · Reproductive Health
  84. Long-term outcomes of Prompt Mental Health Care: A randomized controlled trial
    Solbjørg Makalani Myrtveit Sæther, Marit Knapstad, Nick Grey, Marit Aase Rognerud, Otto R.F. Smith · 2020 · Behaviour Research and Therapy
  85. The Relationship of Lifestyle Factors with the Prevalence of Major Depressive Disorder by Ecological Factors
    Yeon-Jin Kim, Sang‐Ah Lee · 2021 · Psychiatry Investigation
  86. Efficacy and safety of a mineral and vitamin treatment on symptoms of antenatal depression: 12-week fully blinded randomised placebo-controlled trial (NUTRIMUM)
    Hayley A. Bradley, Elena V. Moltchanova, Roger Mulder, Lesley Dixon, Jacki Henderson, Julia J. Rucklidge · 2024 · BJPsych Open
  87. Occupational Outcomes of a Physical Activity Intervention for Post-Secondary Student Mental Health
    Amy E. Nesbitt, Kristina J. Collins, Emily Joan Nalder, Catherine Michelle Sabiston · 2021 · Canadian Journal of Occupational Therapy
  88. Assessing Internalizing Symptoms and Their Relation with Levels of Impairment: Evidence-Based Cutoffs for Interpreting Inventory of Depression and Anxiety Symptoms (IDAS-II) Scores
    Ana De la Rosa-Cáceres, Oscar Martin Lozano, Manuel Sánchez‐García, Fermín Fernández‐Calderón, Gina M. P. Rossi, Carmen Díaz · 2023 · Journal of Psychopathology and Behavioral Assessment
  89. Using WHODAS 2.0 to Assess Functional Impairment in People with Depression: Should Employment Receive More Attention?
    Yu-Chen Chiang, Tsan‐Hon Liou, Hsin‐Chien Lee, Reuben S. Escorpizo · 2021 · International Journal of Environmental Research and Public Health
  90. Mental disorder in limb reconstruction: Prevalence, associations and impact on work disability
    Lauren Rayner, Anna Simpson, Faith Matcham, S. Shetty, Om Lahoti, Graeme Groom, Matthew H. Hotopf · 2016 · Journal of Psychosomatic Research
  91. Path analysis of the chronicity of depression using the comprehensive developmental model framework
    Andrés Fandiño‐Losada, Shrikant I. Bangdiwala, Catharina Lavebratt, Yvonne Forsell · 2016 · Nordic Journal of Psychiatry
  92. Correlates of Disability in Asian Patients With Major Depressive Disorder
    Kanokkwan Eurviriyanukul, Manit Srisurapanont, Pichet Udomratn, Ahmad Hatim Sulaiman, Chia-Yih Liu · 2015 · Perspectives In Psychiatric Care
  93. Mental well-being and recovery in serious mental illness: associations between mental well-being and functional status in the Health Survey for England 2014
    Sarah Chan, Scott Weich · 2020 · BJPsych Open
  94. Evaluating the effect of exercise-based interventions on functioning in people with transdiagnostic depressive symptoms: A systematic review of randomised controlled trials
    Aitana García-Estela, Natalia Angarita‐Osorio, Marlene Charlotte Holzhausen, Javier Mora-Salgueiro, Víctor Pérez, Esther Duarte, Guy Faulkner, Francesc Colom · 2024 · Journal of Affective Disorders
  95. Defining the Evolving Concept of Impairment
    Sam Goldstein, Jack A. Naglieri · 2009 · Springer eBooks
  96. Research Recommendations for Improving Measurement of Treatment Effectiveness in Depression
    Kaloyan Kamenov, María Cabello, Mónica Nieto, Renaldo M Bernard, Elisabeth Kohls, Christine Rummel‐Kluge, José Luís Ayuso‐Mateos · 2017 · Frontiers in Psychology
  97. Improving PHQ9 Utilization Rates in a Primary Care–Mental Health Integration Setting
    Margaret J. Brown, Susie M. Adams, Dawn M. Vanderhoef, Rosanne Schipani, Ashley Taylor · 2019 · Journal of the American Psychiatric Nurses Association
  98. The effect of Remission Status on Work Functioning in Employed Patients Treated for Major Depressive Disorder
    David Sarfati, Kurtis Stewart, Cindy Woo, Sagar V. Parikh, Lakshmi N. Yatham, Raymond Wing Moon Lam · 2016 · Annals of Clinical Psychiatry
  99. Optimal Well-Being After Psychopathology: Prevalence and Correlates
    Andrew R. Devendorf, Ruba Rum, Todd B. Kashdan, Jonathan A. Rottenberg · 2022 · Clinical Psychological Science
  100. Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
    Jia Huang, Yun Wang, Jun Chen, Yanlei Zhang, Zheng Yuan, Yue Li, Josep Maria Haro, María Victoria Moneta, Diego Novick, Yiru Fang · 2018 · Neuropsychiatric Disease and Treatment